AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glavin-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Avin Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glavin-M1 Tablet

Diabex Duo tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo is just one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments are crucial for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. Diabex Duo is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glavin-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glavin-M1 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glavin-M1 Tablet with food.

Common Side effects of Glavin-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glavin-M1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glavin-M1 Tablet whole; do not crush, chew, or divide it. Administer this medication with food.

How Glavin-M1 Tablet works:

Glavin-M1 tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in peripheral tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Glavin-M1 Tablet and alcohol should not be consumed together.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glavin-M1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential hazards before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Maternal use of Glavin-M1 tablets while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glavin-M1 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glavin-M1 Tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glavin-M1 Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glavin-M1 Tablet :

Should you forget a Glavin-M1 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glavin-M1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glavin-M1 Tablet

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glavin-M1 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Glavin-M1 and seek immediate medical attention.
Glavin-M1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glavin-M1 Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glavin-M1 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental Vitamin B12 intake is recommended by some researchers.
Glavin-M1 Tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, like glucose tablets, honey, or fruit juice, at all times.
Combining Glavin-M1 tablets and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glavin-M1 Tablet
60
MRP 70
14% off